Hanna Kim
National Institutes of Health(US)Cleveland Clinic(US)Royal Marsden NHS Foundation Trust(GB)City College of San Francisco(US)University of California, San Francisco(US)Korea University(KR)University of Michigan(US)Samsung Medical Center(KR)Yale University(US)National Institute of Arthritis and Musculoskeletal and Skin Diseases(US)
Publications by Year
Research Areas
Inflammatory Myopathies and Dermatomyositis, Eosinophilic Disorders and Syndromes, Inflammasome and immune disorders, T-cell and B-cell Immunology, Atrial Fibrillation Management and Outcomes
Most-Cited Works
- → Activated STING in a Vascular and Pulmonary Syndrome(2014)1,353 cited
- → An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome(2014)727 cited
- → JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies(2018)508 cited
- → Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production(2015)332 cited
- Identification of c-myc responsive genes using rat cDNA microarray.(2000)
- → Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases(2019)230 cited
- → Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.(1993)217 cited